The Life Sciences Report – January 2024 | Wilson Sonsini Goodrich & Rosati

This issue features articles on the firm’s Business Advisory Practice supporting Nervosave Therapeutics’ U.S. expansion; the USPTO’s forthcoming guidance on AI innovation protection;...

Related Keywords

Phoenix ,Arizona ,United States ,Ed Shenkan ,Kenneth Greenberg ,Wilson Sonsini ,Life Sciences Investment Forum ,Business Advisory Practice ,Phoenix Conference ,Sciences Investment Forum ,